GLP1R and diabetes mellitus: Thus, GLP-1R agonists prevent or delay the development of diabetes in both db/db mice and Goto-Kakizaki rats, and diminish the severity of diabetes in rats after partial pancreatectomy or neonatal administration of streptozotocin [80,81,82,83].